# Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis

> **NCT06558461** · PHASE2,PHASE3 · COMPLETED · sponsor: **Can Tho University of Medicine and Pharmacy** · enrollment: 140 (actual)

## Conditions studied

- Acute Bronchiolitis

## Interventions

- **DRUG:** 3% Sodium Chloride
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT06558461
- **Lead sponsor:** Can Tho University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-05-27
- **Final completion:** 2024-05-28
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558461, "Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06558461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*